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“Chromosomes are the largest and least well understood of cellular organelles. The challenge lies in a combination of complex biochemistry and inhomogeneous structure.” 
This statement, made by Roger Kornberg more than ten years ago1, 
reflects the longstanding interest and effort directed at understand-
ing the regulation of the eukaryotic genome. The genome is in fact 
assembled into a structure termed chromatin, and chromatin com-
position is highly heterogeneous depending on the cell type and 
the cell-cycle stage. Importantly, chromatin composition is mostly 
locus specific and determines that locus’ function. Establishing the 
locus-specific composition of chromatin represents a major techni-
cal challenge, and this remains an outstanding issue. Indeed, know-
ing the components of a system composition is a major step toward 
understanding how it works.
Currently, genome biology studies are based on mapping chro-
matin proteins and/or epigenetic marks and correlating their pres-
ence with genome activities, such as transcription, replication and 
repair. Combined with next-generation sequencing technologies, 
chromatin immunoprecipitation (ChIP) has been instrumental 
in advancing our knowledge of chromatin biology. However, this 
approach is limited by the requirement for prior knowledge of the 
factor to assay and is dependent on the availability and specificity of 
antibodies2. Improvements in ChIP and in mass spectrometry (MS) 
techniques have also made it possible to explore the interactome of 
a factor in the context of chromatin and to identify novel regula-
tors3–8. However, these approaches are not suitable for describing 
the composition of a specific chromatin locus—by which, in the 
context of this work, we mean any specific genomic region, of vary-
ing size, primarily defined by its biological function: for example, 
a ‘promoter’ promotes RNA transcription of a gene or a ‘telomere’ 
protects a chromosome end.
DNA affinity pulldown is a well-known approach to identify fac-
tors binding to a specific DNA sequence9. Moreover, in-vitro-pre-
pared mono- and polynucleosomes and naked DNA with specific 
modifications have been used for affinity pulldown in combination 
with MS10–13 to identify proteins associated with epigenetic marks. 
However, in  vivo regulation processes, which involve specific 
sequences and a large and often only partially known array of spe-
cific histone and DNA modifications, are very difficult to recapitu-
late in vitro.
Before 2010, only a few approaches were available for isolating 
and analyzing specific loci as chromatin14–17. With the populariza-
tion of proteomics, novel strategies based on MS were developed to 
comprehensively identify proteins that interact with a locus of inter-
est18–23. Although initially only relatively large parts of the genome 
(i.e., repetitive loci) could be quantitatively isolated to sufficient 
purity, a series of new approaches have been established for deter-
mining the proteome of small single-copy loci from mammalian 
genomes. In this critical review of currently published strategies, 
we first describe the biochemical challenges in obtaining a specific 
locus of chromatin as a pure entity for downstream MS analyses. 
Then, we discuss the published approaches and highlight their 
advantages and limitations.
The biochemical challenges
Regardless of the strategy, locus-specific chromatin purification 
requires a few common steps: (i) the preparation of soluble chroma-
tin that retains as many relevant molecular interactions as possible; 
(ii) a specific and efficient method to capture the locus of interest; 
and, importantly, (iii) an enrichment factor in proportion with the 
relative abundance of the locus in the genome.
Chromatin preparation and stoichiometry of chromatin com-
ponents. Chromatin is a heterogeneous mixture of nucleic acids 
and proteins, each engaged in dynamic complexes with different 
affinities for noncovalent interactions and with distinct stoichiom-
etry. Moreover, the pH and ionic strength requirements to main-
tain these interactions and solubility in  vitro vary hugely among 
individual chromatin components24. Therefore, the ideal milieu 
to preserve chromatin integrity and complexity in the native state 
is practically unattainable in a test tube. Yet compromises can be 
made, and several classical native chromatin preparation proto-
cols exist24 that can be used for functional studies. However, the 
tradeoff necessary to maintain solubility by using chelating com-
pounds, salts and/or detergents inevitably leads to the dissocia-
tion of important interactors or to the induction of composition 
rearrangements. To limit these effects, chromatin can be stabilized 
by covalent chemical crosslinking before extraction—usually with 
formaldehyde25 (Box 1)—to maintain as many interactions as 
possible. Another key parameter is the absolute abundance of the 
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chromatin locus to be purified because this will determine the 
amount of required starting material. The current detection limit 
for peptide identification by standard MS in a practical setting is 
in the low femtomole (10−15 mol) range (Box 2). This represents 
a minimum of 600 million molecules. Assuming a (theoretical) 
purification yield of 100%, the isolation of a specific single-copy 
locus requires half a billion diploid cells as input material to iden-
tify the most abundant components at that locus (often structural 
components, such as histones). In practice, however, the amount 
of starting material should be carefully considered in light of the 
end goal of locus-specific proteome characterization because regu-
latory components (such as enzymes) are usually several orders of 
magnitude less abundant than structural components. Therefore, 
their identification might require greater amounts of starting mate-
rial. For example, at pericentromeric regions, the SUV39H histone 
methyltransferase is two orders of magnitude less abundant than 
nucleosomes26. In nonsynchronized cells, the abundance of the 
telomerase enzyme, which is crucial for telomere maintenance, is 
several orders of magnitude lower on telomeres than are the sub-
units of the most abundant protein complex associated with telo-
meres, the shelterin complex. Consequently, substantially more 
starting material is required to identify telomerase in telomere 
chromatin preparations compared to shelterin subunits.
Locus-specific capture. From a biochemical point of view, locus-
specific purification represents a tremendous technical challenge 
partly because a specific locus often shares components (such as 
histones) with other loci. This strongly limits the efficiency of clas-
sical separation approaches that rely on differential biophysical 
separation criteria (for example, ionic strength, size or solubility). 
Moreover, as a small and unique locus represents only a minute 
fraction of the entire genome, the chosen strategy must not only 
discriminate, but also sufficiently enrich, that locus from a gigan-
tic amount of similar entities that tend to copurify. The challenge 
is comparable to that of finding a specific straw, not a needle, in a 
haystack. Few targets are uniquely bound by specific protein fac-
tors and are abundant enough to be isolated using a single immu-
noaffinity for a protein specific to the target27,28. However, in most 
cases, the uniqueness of a chromatin locus is embodied by its 
DNA sequence and its distinctive combination of bound factors. 
Therefore, sequence-specific hybridization capture has been the 
strategy of choice. Alternatively, a target locus can be modified by 
adding exogenous sequences bound by unique adapters, as we will 
also detail later.
The enrichment factor: the key signal-to-noise ratio parameter. 
In ChIP, chromatin components are mapped to specific genomic 
regions. As mapping is the endpoint in this analysis, background 
signal is unimportant as long as the enrichment factor is suffi-
cient to discriminate between specific binding to a unique region 
and background binding to a non-relevant region of the same size. 
This is usually assessed by quantitative PCR. In a ChIP-sequencing 
experiment, only a minority of the tens of millions of sequencing 
reads are informative and contribute to the genuine signals (‘peaks’), 
without major impact on mapping. Locus-specific isolation meth-
ods have an entirely different objective. Indeed, the enrichment fac-
tor of the target locus should be calculated relative to the rest of the 
genome and not relative to another non-targeted region of similar 
size, because in these approaches, all non-targeted regions (i.e., the 
rest of the genome) and not just one control region contribute to 
the background (Figs. 1 and 2a). This is crucial for the success of 
the experiment and for high-confidence MS identification of locally 
bound factors.
The relative abundance of the target (i.e., the target size relative 
to the genome size) drastically affects the purification requirements. 
For instance, mouse pericentromeric repeats (comprising ~3% of 
the genome) can be captured to levels above background with strat-
egies that enrich this locus at least 17-fold (i.e., 51% of the purified 
Box 1 | Native chromatin preparations compared to formaldehyde crosslinking
Crosslinking is the process of joining two or more molecules by 
covalent bonds using chemicals or other physical means, such as 
exposure to UV light. Many crosslinkers are commercially avail-
able, and these vary in solubility, spacer arm length, reactivity, 
functional groups, reversibility and price. The chemical reaction 
of formaldehyde (HCHO) with amino and imino groups is com-
monly used to stabilize protein–DNA complexes and analyze 
chromatin composition. Indeed, this inexpensive reagent has 
critical advantages: it is cell membrane permeable, and its small 
size allows it to diffuse rapidly inside biological materials. Its small 
size also permits the crosslinking of amino acids and nucleic ac-
ids, which requires very close proximity (≤2 Å). It is commonly 
believed that formaldehyde generates nonspecific crosslinks, but 
we have found no experimental evidence for this in the literature. 
Formaldehyde is the most popular chemical used in ChIP, immu-
nofluorescence and chromatin conformation capture approaches, 
and to the best of our knowledge, it does not generate artifactual 
signals. Similarly, the results of pioneering chromatin studies ar-
gue against nonspecific crosslinking because crosslinks could not 
be detected between bovine serum albumin (BSA) and DNA after 
incubation of DNA with highly concentrated BSA (50 mg/ml), 
which does not normally bind to DNA, in 1% formaldehyde for 
>4 days57. This suggests that efficient crosslinking requires stable 
interactions. However, this also represents a limitation of formal-
dehyde, because true, but transient, in vivo interactors might not 
efficiently be retained on chromatin, as has been convincingly 
shown for some MeCP2 mutants binding to pericentromeres58. 
Formaldehyde also readily generates protein–protein crosslinks, 
which results in the recovery of proteins indirectly bound to spe-
cific regions through other proteins25. This forms the rationale for 
chromosome conformation capture approaches. This feature of 
formaldehyde might also lead to the nonspecific crosslinking of 
abundant proteins to specific loci. Therefore, any ‘unexpected’ pro-
tein association to a given locus requires validation by orthogonal 
methods, and could explain the presence of some noncanonical 
proteins in locus-specific purifications. Moreover, some proteins 
might not be crosslinked by formaldehyde, and thus will be lost 
during preparation. This issue might be addressed by the use of 
other crosslinking agents, which can help stabilize certain tran-
scription factors on chromatin59. Furthermore, formaldehyde can 
affect epitope recognition by antibodies that are used for ChIP, 
and this may influence the yield. Finally, enzymatic treatments of 
chromatin after crosslinking are often inhibited or less efficient, 
preventing functional analyses. For these reasons, several research 
groups in the chromatin field have developed native chromatin 
purification approaches. Native conditions allow very efficient 
immunoprecipitation, a major advantage for ChIP experiments, 
which can then be quantitatively analyzed without PCR ampli-
fication steps60. However, native chromatin preparation requires 
enzymatic digestion, and consequently some chromatin fractions 
are poorly solubilized, thus preventing their analysis. Moreover, 
native preparations are not suitable for proteins that are not tightly 
bound to chromatin and are susceptible to generating more non-
specific chromatin rearrangements.
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material will be pericentromeric). Enriching 3% of the genome by 
33-fold would lead to near-homogeneity of the purified preparation 
(i.e., 99% of the purified material would be pericentromeric). On 
the other hand, for a single-copy 3-kb promoter element (0.0001% 
of the human genome), a 1-million-fold enrichment would be 
required to reach near homogeneity (Fig. 2b).
Although an adequate enrichment factor depends on the size 
of the target site relative to the genome size and on the capture 
efficiency, noise depends on the capture specificity and on the 
stringency of the procedures used to eliminate off-target and non-
specifically associated factors. An easy way to estimate target-locus 
enrichment is to assess its abundance relative to that of another 
non-target locus of similar size by quantitative PCR. In the starting 
material, this ratio should be equal to 1, while the value in the puri-
fied fraction represents a good estimate for enrichment.
In most cases, single-step affinity purification generates at best 
a 1,000-fold enrichment for unique proteins in solution. Therefore, 
if not combined with additional purification steps, the 1,000-fold 
enrichment of a human 3-kb locus will yield a proteome constitut-
ing 99.9% background proteins and 0.1% locus-specific factors. 
Nevertheless, even with such enrichment values, it is still possible to 
identify single-locus-specific factors, if they are significantly bound 
to the target and not elsewhere, but not to determine the compre-
hensive locus-specific composition.
Locus-specific isolation strategies
Direct hybridization of capture probes to chromatinized DNA. 
DNA sequence specificity can be exploited for chromatin isolation. 
Hybridization-based capture approaches are probably the most 
straightforward methods because they do not require genetic engi-
neering. On the other hand, they always involve chemical crosslink-
ing to maintain protein–DNA interactions because hybridization 
requires denaturation of the target dsDNA or other means to make 
the target sequence single stranded (such as exonuclease digestion).
Proteomics of isolated chromatin segments (PICh) was the first 
reported method that combines locus purification and MS (Fig. 3a). 
PICh does not require either prior knowledge about the proteins that 
bind to the locus of interest or genetic engineering of target cells. 
PICh is based on the hybridization of synthetic nucleic acid probes 
(‘locked’ nucleic acids as well as modified RNA) that are comple-
mentary to the locus of interest. These probes bind to DNA with very 
high specificity and stability and harbor the biotin analog desthio-
biotin, which can be captured on streptavidin-conjugated beads and 
eluted with biotin. This allows the specific release of probe–chro-
matin hybrids in solution, while a significant amount of non-target 
chromatin remains bound to the streptavidin matrix. This consider-
ably reduces the noise and significantly contributes to the enrich-
ment value. After chromatin decrosslinking, proteins are identified 
by MS. PICh was initially used to purify telomeric chromatin (0.01% 
of the human genome). As expected, the most abundant proteins 
were the six shelterin proteins, validating the approach. Moreover, 
PICh revealed that the composition of telomeric chromatin is more 
complex than anticipated, and allowed the identification of novel 
factors and consequent characterization of novel regulation pro-
cesses18,29–34. PICh has been combined with SILAC for quantitative 
analyses, for instance to measure changes in pericentromeric and 
telomeric regulation by heterochromatin enzymes35,36. In this setup, 
PICh allowed the identification and quantification of post-transla-
tional modifications of histones. At both targets, the ensemble of 
histone post-translational modifications (the code) was consistent 
with the proteome data (readers and writers/erasers), indicating that 
the method is suitable for studying chromatin regulation and for 
testing the histone code hypothesis. An important limitation of this 
method is the difficulty of obtaining PICh probes from oligonucle-
otide companies. Moreover, PICh capture probes only work on the 
3′ end of the target fragment, a constraint that has major implica-
tions for the preparation and fragmentation of soluble chromatin37. 
In its current version, PICh provides an enrichment factor of up to 
10,000-fold. Therefore, it is not appropriate for studying the compo-
sition of single-copy small loci (~3 kb) from mammalian genomes. 
Indeed, as discussed before, only 1% of PICh-purified proteins 
would be target specific in such a case.
Box 2 | The Ms challenges
Although the theoretical detection limit for peptide identifica-
tion of a digested purified protein is in the zeptomole (10−21) to 
attomole (10−18) range61,62, the current detection limit for peptide 
identification from a complex peptide mixture by standard MS in 
a practical setting is in the low femtomole (10−15 mol) range. As 
this requires a minimum of 600 million molecules, it is critical 
to achieve high enrichment of a single-locus target while avoid-
ing sample loss. Although adaptations of biochemical procedures 
will allow improving enrichment and purity, the inclusion of one 
or several recently optimized MS workflows might be required 
to obtain a comprehensive single-locus proteome. First, the data 
acquisition mode of modern mass spectrometers can be adjusted 
between ‘conventional’ data-dependent acquisition (DDA) and 
data-independent acquisition (DIA). Although DDA is extremely 
powerful, it relies on ‘random’ selection of peptides. In practice 
this means that peptides with the highest intensity are selected 
first, resulting in the overrepresentation of high-intensity peptides. 
Conversely, in DIA all peptides in a defined mass-to-charge win-
dow are selected and fragmented, thus allowing the identification 
of all peptides in a complex mixture63. The superiority of DIA for 
measuring low-abundance proteins in a complex mixture has been 
recently demonstrated64. This acquisition mode should be espe-
cially powerful for the analysis of samples that are dominated by 
highly abundant structural proteins, such as histones, in the case 
of single-locus purification. Second, new methods are currently 
being developed for the online fractionation of peptide mixtures 
using ion separation in inert gas under the influence of an electri-
cal field. These approaches, collectively referred to as ion mobility 
spectrometry (IMS), exist in several versions depending on the 
IMS instrumentation. IMS can be broadly divided in two groups: 
drift-tube ion mobility spectrometry (DTIMS) and high-field 
asymmetric-waveform ion-mobility spectrometry (FAIMS). These 
methods are used to reduce peptide coelution and cofragmenta-
tion, and they can significantly improve the accuracy and compre-
hensiveness of multiplexed proteomic analyses65. Recently, it was 
shown that FAIMS implementation in the MS workflow results in 
higher sensitivity and increases the quantifiable peptides from a 
complex mixture compared to experiments without FAIMS66,67. 
Finally, as single-locus purification experiments will yield only 
limited amount of material for liquid chromatography–mass spec-
trometry (LC-MS) analysis, even when using billions of input 
cells, it will be critical to reduce sample loss before and during MS 
measurements. This could be achieved by performing (part of) the 
experiment and/or sample preparation on a microfluidics device 
because this makes it possible to identify protein complexes from 
minute amounts of input material68. During MS measurements, 
sample loss could be further minimized by spiking in labeled 
peptides that serve as carrier peptides. This approach has recently 
proven its value toward developing single-cell proteomics work-
flows that also deal with low amounts of input material69.
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A similar strategy, hybridization capture of chromatin-associ-
ated proteins for proteomics (HyCCAPP), was later developed to 
characterize the composition of repetitive and single-copy loci in 
yeast. Depending on the target, HyCCAPP provides an enrichment 
of 80- to 800-fold relative to another non-target locus, making it 
suitable for characterizing repeated (or large) loci38,39. HyCCAPP 
uses DNA probes that are easier to synthesize than PICh probes, 
a critical advantage when targeting large loci with complex 
sequences. However, DNA probes bind with lower stability, and this 
partly explains the lower target enrichment compared with PICh, 
although the comparison is difficult because the targeted loci are 
different. HyCCAPP was used to purify a single-copy ~1.4-kb locus 
from the yeast genome (~0.01% of the genome)23. With an enrich-
ment value of 1,000-fold, only 10% of the material (i.e., 0.01% × 
1,000) in the purified fraction should be locus specific. Such a per-
centage might be sufficient to discover specific interactors if they 
are abundant at the target (signal) and not elsewhere (noise), but 
insufficient to enrich for proteins that are also abundant elsewhere 
(such as histones). Thus, in its current form, HyCCAPP is unlikely 
to be suitable to describe single-locus-specific protein composition 
and the local histone code regulation.
New, more efficient hybridization-based locus-specific chroma-
tin purification approaches might be developed by taking advantage 
of DNA nanotechnologies that could help to improve the kinetics 
of assembly and stabilization of the hybridized probes. Multiplexed 
HyCCAPP has been used to target several loci from the same start-
ing material and to effect the orderly release of each target for down-
stream analysis40. We are currently developing novel PICh capture 
probe designs and optimizing multistep enrichment protocols. Our 
efforts, in combination with improved MS instruments and pipe-
lines, might allow the development of a robust method to establish 
the composition of single-copy targets from mammalian genomes.
Purification based on nuclease-dead Cas9. CRISPR-Cas9 technol-
ogy enables precise targeting of regions of interest in the genome, 
and this has been exploited for identifying locus-specific proteins. 
In these approaches, hybridization to the target DNA sequence 
is also used for locus-specific isolation, but the probe, made of a 
20-nucleotide-long guide RNA, is associated with a nuclease-dead 
Cas9 (dCas9) that can be functionalized with affinity tags (Fig. 3b). 
In the initial attempts using single-antibody-based affinity purifica-
tion after binding of the guided dCas9 to the target, the genome-
scale specificity and biological relevance of the interacting proteins 
were not evaluated22,41. In fact, a single-locus guided dCas9 can bind 
to tens to hundreds of off-target sequences42, and this could lead to 
the copurification of relatively large amounts of irrelevant regions. 
This issue was recently addressed by using a biotinylatable dCas9 
protein to purify specific chromatin loci in human cells43. The 
method is named CAPTURE (CRISPR affinity purification in situ 
of regulatory elements) and involves the simultaneous expression in 
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Fig. 1 | The potential information gained from locus-specific research depends on the target sample enrichment. Indeed, establishing the local 
composition and identifying novel factors that uniquely bind to the locus of interest are two entirely different questions that require vastly different 
enrichment factors.
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a given cell type of a specific guide RNA along with a dCas9 harbor-
ing a target peptide that can be biotinylated in vivo by the bacterial 
biotin ligase BirA (also coexpressed in these cells; see Fig. 3b). As 
a proof of principle, CAPTURE was first used to purify telomeres, 
and it allowed the identification of several telomere-specific binding 
proteins. This suggests that CAPTURE can sufficiently enrich telo-
meric chromatin. However, three major shelterin proteins, TRF1, 
TIN2 and TPP1, were not retrieved. As dCas9 is a large protein 
known to perturb chromatin regulation upon binding, it is pos-
sible that dCas9 binding along the telomere sequence might exclude 
some relevant proteins from telomeres in vivo. CAPTURE was then 
used to purify small single-copy loci from the human β-globin clus-
ter, and the amount of captured off-target material was evaluated 
by ChIP-seq analysis. The specific enrichment of each single-copy 
targeted locus was relatively high, in the range of 103, while that of 
the predicted off-targets was lower (100 to 102). Using label-free 
approaches, appropriate negative controls (including a cell line in 
which the target was removed by knockout) and multiple replicates, 
CAPTURE allowed the retrieval of several locus-specific proteins, 
demonstrating its usefulness.
More recently the Tjian laboratory developed a method called 
CLASP (Cas9-locus-associated proteome)44. Unlike with in  situ 
targeting methods, in CLASP affinity capture is performed in vitro 
using solubilized crosslinked chromatin on an immobilized dCas9 
that binds to specific guide RNAs. This approach does not require 
genetic engineering, and it circumvents the issue of possible changes 
in the local regulation and endogenous composition upon dCas9 
tethering in vivo. As a proof of principle, CLASP was first employed 
to retrieve the telomere proteome from human cells. CLASP suc-
cessfully recovered several shelterin proteins; however, TRF1, TIN2 
and POT1 were not retrieved, suggesting a bias in the method. 
Then, CLASP was used to purify the repetitive histone locus from 
Drosophila cells. The characterization of two novel histone gene 
regulators revealed that they were bound to the histone mRNA, 
implying that CLASP might also target ribonucleoprotein com-
plexes. Classical transcription factors and molecules involved in 
the main cell machineries (such as the replisome and spliceosome) 
were absent, suggesting that significant DNA-based processes can 
be missed with CLASP.
Purification based on the binding of sequence-specific proteins. 
If the locus of interest is abundant enough and is significantly bound 
by proteins not found elsewhere in the genome, these proteins can 
be crosslinked to chromatin, immunoprecipitated and analyzed 
by MS-based approaches (Fig. 3c). For instance, a telomere pro-
teome was established using anti-shelterin antibodies27,28. When the 
locus of interest is not uniquely bound by an endogenous protein, 
sequence-specific adaptor proteins can be designed and expressed 
to bind to the region of interest. Transcription-activator-like effec-
tor (TALE) domains can be designed to bind to specific DNA 
sequences45. When tagged, the bound TALE proteins can be immu-
noprecipitated to enrich the associated chromatin segment (Fig. 3d). 
This strategy was used to enrich for the GAL1 gene under native 
conditions in yeast19,46 and for telomeric chromatin in fixed cultured 
cells47. However, in this last study, shelterin proteins were absent, 
suggesting that TALE binding might compete with the binding of 
biologically relevant telomere proteins in  vivo. Another strategy 
involves significant genetic engineering of the target cells (Fig. 3e). 
The locus of interest is modified to harbor specific DNA sequences 
that can be tightly bound by adaptor proteins, such as Tet or LexA. 
After insertion of these specific sequences at the locus of interest and 
coexpression of the adaptor protein, the locus is enriched by immu-
noprecipitation. By introducing an orthogonal enrichment step that 
involved the specific excision of the target from the bulk chroma-
tin in yeast, Kornberg’s group was able to enrich the PHO5 gene 
promoter by 100,000-fold48. However, the use of native conditions 
might have led to loss of important interactors, as confirmed by MS 
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Fig. 2 | signal-to-noise ratio issues. a, Example of the purification of a telomere locus from the human genome. Telomere-binding proteins have distinct 
stoichiometry for telomere DNA and represent minute amounts of the total proteome. To establish the telomere composition, telomere-binding proteins 
must represent the major components after purification. b, Enrichment fold required for locus characterization according to locus relative abundance.
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recovered21,48. The LexA affinity strategy was also used to investigate 
the proteins and histone post-translational modifications associated 
with the single-copy GAL1 promoter region in yeast19 under condi-
tions of transcription silencing or induction. With this method, the 
1,000-bp target was enriched by about fivefold relative to a non-tar-
geted region (ACT1), suggesting that GAL1 represented only 0.04% 
of the purified material. The chicken β-globin HS4 insulator was 
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Fig. 3 | Different approaches for locus-specific chromatin characterization. a, Oligonucleotide-based capture (pICh and HyCCApp). b, dCas9-based 
capture (CApTURE, CLASp, CRISpR ChAp-MS and enCHIp). c, Immunoprecipitation of factors restricted to the locus of interest (QTIp). d, TALE-based 
capture. e, Capture methods that require editing the target sequence (genomic engineering). f, proximity biotinylation (CasID, Glopro, C-BERST and 
CApLOCUS); note that this does not address locus composition but rather is intended to discover locus-specific factors. g, Genomic strategy developed in 
yeast (Epi-Decoder).
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The Tet system was used to enrich a single-copy transgene (the 
human fetal-γ-globin gene) in mice20. To this aim, the Tet adaptor 
was fused with different tags, including a biotag that can be biotinyl-
ated by BirA. The method allowed the identification of 14 unique 
proteins, including regulatory proteins involved in γ-globin gene 
repression.
Proximity-labeling approaches. The BirA protein targets a lysine in 
a specific peptide sequence for biotinylation. However, after muta-
tion into BirA*, its biotin ligase activity becomes promiscuous and 
it can biotinylate any lysine in the surrounding proteins. These bio-
tinylated factors can then be captured with streptavidin and identi-
fied by MS. This feature was first used to develop a method named 
BioID to identify proteins in the vicinity of a given protein factor50. 
Briefly, the protein of interest is fused with BirA* and expressed 
in cell lines that are cultured in the presence of biotin. Successful 
experiments using BioID largely depend on the distribution of 
BirA-tagged proteins during the biotinylation step, which can last 
up to several hours. The first chromatin-based method using BirA* 
was named CasID51. In CasID (Fig. 3f), BirA* is fused to dCas9, and 
then dCas9 is guided by specific guide RNAs to telomeres and peri-
centromeric regions of mouse cells. The great advantage of using 
promiscuous BirA* biotinylation is that there is no need for specific 
strategies to maintain relevant protein interactions in the chroma-
tin preparations in vitro. Indeed, biotinylation around dCas9 occurs 
in vivo, and after cell lysis, biotinylated proteins are recovered in a 
single high-stringency affinity enrichment step. CasID successfully 
recovered some shelterin proteins at telomeres51, but as with other 
dCas9-based methods described above, abundant telomeric factors, 
such as TRF1, RAP1 and POT1, were missing. Another approach, in 
which BirA* was fused to TRF1, was used successfully to analyze the 
proteome of TRF1 neighboring factors and retrieved both expected 
and novel telomere-binding proteins52.
Other proximity-labeling-based approaches have been devel-
oped more recently: dCas9–APEX2 biotinylation at genomic ele-
ments by restricted spatial tagging (C-BERST), CAPLOCUS and 
genomic locus proteomics (GLoPro). All three methods are based 
on dCas9 fused to the engineered ascorbate peroxidase APEX2, a 
protein that generates highly reactive biotin-phenoxyl radicals using 
biotin-phenol and hydrogen peroxide53,54,55. These radical entities 
are short-lived and can interact with tyrosine residues in proteins 
present in a restricted 20-nm radius. APEX2 biotinylation is a very 
rapid and efficient process, and incubation times are significantly 
shorter (about a minute) than with BirA*-based methods. C-BERST 
and CAPLOCUS were used to establish the proteome of telomeres 
as a proof of principle. C-BERST was also successfully employed to 
identify alpha-satellite pericentromeric and centromeric proteins54. 
GLoPro was used to identify proteins bound to single-copy pro-
moter elements of the telomerase TERT and of MYC55. Many fac-
tors not known to have canonical functions in transcription were 
identified, and some were validated by ChIP. The authors noted that 
expected binding proteins, such as canonical promoter factors (for 
example, general transcription factors), or even RNA polymerase 








Competition-induced chromatin composition change














Fig. 4 | Major limitations of the CrIsPr-dCas9- and TaLe-based targeting systems. a, dCas9 binds to nonspecific targets with a significant probability. 
b, As most of the expressed dCas9 is not bound to the target, when dCas9 is fused with BirA or ApEX, the promiscuous biotinylation of neighboring 
factors generates a very high background. c, Chromatin conformation can modulate Cas9 binding efficiency. d, Simple-repeat multitargeting by dCas9 can 
compete with resident factors and change the endogenous composition.
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comparable abundance in the negative controls. This suggests that 
non-guided dCas9 or dCas9 associated with a negative-control 
guide RNA significantly biotinylates biologically relevant proteins 
that are discarded in the analyses. One caveat with all proximity-
labeling methods is that most of the expressed dCas9 molecules 
(hundreds, if not thousands, per cell) are not associated with the 
Table 1 | List of locus-specific purification methods
Principle Name Input (cell 
numbers)

















HyCCApp 3.3 × 109 
to >1011
Yeast, human α satellites, rDNA, 
X element, GAL1-10, 
ENO2 etc.
Crosslinked 23,38,40 Does not affect the 





QTIp 5 × 107 to 
108
Human Telomeres Crosslinked 27,28 Restricted to telomeres.
proximity biotinylation TRF1-BioID 6 × 107 Human Telomeres Native 52 Requires establishment of 




RS-TAp* 1011 to 1.5 
× 1012
Yeast rDNA, PHO5 Native 21 First single-locus purification 
effort with the goal of 
analyzing chromatin 
structure.
ChAp-MS 1011 Yeast rDNA, GAL1 Crosslinked 19 Requires establishment of 
stable cell lines.
i-ChIp 5 × 107 Mouse β-globin HS4 
insulator
Crosslinked 49 Requires establishment of 
stable cell lines.








TAL-ChAp-MS 1011 Yeast GAL1 Native 46 Requires establishment of 
stable cell lines.








1 × 1011 Yeast GAL1 Crosslinked 22 Requires establishment of 
stable cell lines.
CApTURE 0.25 × 109 
to 1 × 109
Human β-globin cluster, 
telomeres








Crosslinked 44 Recombinant dCas9 used 
as a hook in vitro; does not 




CasID 4 × 107 Mouse Telomeres, major and 
minor satellites




n.d. Human hTERT, cMYC Native 55 Requires establishment of 
stable cell lines.
C-BERST 6 × 107 Human Telomere, α satellites Native 54 Requires establishment of 
stable cell lines.




Epi-Decoder 1.5 × 109 Yeast Barcoded reporter 
gene at the HO locus
Crosslinked 56 Independent of MS but 
relies on high-throughput 
sequencing. Restricted to 
yeast.
unp., unpublished; n.d., not determined.
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target locus, and some are even significantly bound to nonspecific 
targets (Fig. 4a). This is particularly problematic when a small sin-
gle-copy locus is targeted, because only one dCas9 molecule per 
genome is specifically bound at any given time. This implies that 
the vast majority of the biotinylated proteome is nonspecific and 
contributes to noise (Fig. 4b). Moreover, as dCas9 is a rather large 
molecule, its binding efficiency might be greatly influenced by the 
chromatin structure (Fig. 4c). Finally, dCas9 binding might com-
pete out the binding of biologically relevant interactors (Fig. 4d). 
Appropriate controls and multiple replicates might be sufficient to 
mitigate these issues. Nevertheless, dCas9 proximity labeling-based 
methods might be useful to identify proteins that bind only to the 
single-copy target and not elsewhere.
Concluding remarks
In the genome, each locus is defined by a unique combination of 
proteins that support local functions. For instance, telomeres are 
bound by shelterin proteins for chromosomal capping, centromeres 
by CENP proteins that specify kinetochore position in mitosis, 
transcribed genes by RNA polymerases and cofactors, and replica-
tion origins by replication initiation factors. In many of the stud-
ies described in this article (Table 1), particularly when focused 
on the analysis of single-copy small loci, proteomic analysis often 
retrieved noncanonical and unexpected protein factors with high 
confidence, while expected proteins that normally define the target 
biological function were absent. In our view, this represents a mat-
ter of concern and a clear indication of the limitations of the current 
methods: although such approaches can be used to discover some 
locus-specific proteins, the major signal-to-noise ratio problem 
will need to be addressed before they can fully describe the spe-
cific composition of single-copy loci. We think that this is a bio-
chemical challenge that should be prioritized in developing future 
locus-specific capture methods. A second problem is single-locus 
abundance, which, by definition, is only two molecules per dip-
loid genome. Without peptide amplification methods, this implies 
working with huge amounts of starting material. This challenge will 
probably be solved by the continuous improvements to MS tech-
nology (Box 2) or through the use of entirely different strategies, 
as exemplified by the recent development of Epi-Decoder (Box 
3). Epi-Decoder relies on generating yeast library strains in which 
genes of interest carry a universal affinity tag as well as a unique, 
gene-specific DNA barcode. All tagged strains are subsequently 
subjected to a single chromatin immunoprecipitation using a tag-
specific antibody, after which gene-specific barcodes are sequenced 
and quantified. Quantification of the barcodes directly reflects the 
abundance of each assayed protein on a given target. Epi-Decoder 
was used to interrogate the composition of a transcription start site 
of a reporter gene using 4,000 tagged yeast strains and retrieved, as 
expected for this type of locus, RNA polymerase II subunits and 
canonical transcription initiation factors. This ‘genomics’ method 
is a very promising alternative for single-locus affinity purification, 
although it has thus far only been applied to yeast.
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